3.23.1 html 92 179 1 false 33 0 false 5 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/StatementUnauditedCondensedConsolidatedBalanceSheets UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 100020 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/StatementUnauditedCondensedConsolidatedBalanceSheetsParenthetical UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 100040 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 100050 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersDeficitEquity UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY Statements 6 false false R7.htm 100060 - Disclosure - Nature of the Business Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureNatureOfBusiness Nature of the Business Notes 7 false false R8.htm 100070 - Disclosure - Basis of Presentation and Significant Accounting Policies Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureBasisOfPresentationAndSignificantAccountingPolicies Basis of Presentation and Significant Accounting Policies Notes 8 false false R9.htm 100080 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 9 false false R10.htm 100090 - Disclosure - Property and Equipment Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosurePropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 100100 - Disclosure - Accrued Expenses Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureAccruedExpenses Accrued Expenses Notes 11 false false R12.htm 100110 - Disclosure - Debt Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureDebt Debt Notes 12 false false R13.htm 100120 - Disclosure - Advances From Collaboration Partners, Legal and Other Contingencies Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureAdvancesFromCollaborationPartnersLegalAndOtherContingencies Advances From Collaboration Partners, Legal and Other Contingencies Notes 13 false false R14.htm 100130 - Disclosure - Stockholders' Equity Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureStockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 100140 - Disclosure - Stock-based Compensation Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureStockBasedCompensation Stock-based Compensation Notes 15 false false R16.htm 100150 - Disclosure - Recurring Fair Value Measurements Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/DisclosureRecurringFairValueMeasurements Recurring Fair Value Measurements Notes 16 false false R17.htm 100160 - Disclosure - Other Expense, Net Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureOtherExpenseNet Other Expense, Net Notes 17 false false R18.htm 100170 - Disclosure - Net Loss Per Share Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShare Net Loss Per Share Notes 18 false false R19.htm 100200 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureBasisOfPresentationAndSignificantAccountingPoliciesPolicies Basis of Presentation and Significant Accounting Policies (Policies) Policies http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureBasisOfPresentationAndSignificantAccountingPolicies 19 false false R20.htm 100210 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssets 20 false false R21.htm 100220 - Disclosure - Property and Equipment (Tables) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosurePropertyAndEquipment 21 false false R22.htm 100230 - Disclosure - Accrued Expenses (Tables) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureAccruedExpenses 22 false false R23.htm 100240 - Disclosure - Debt (Tables) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureDebtTables Debt (Tables) Tables http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureDebt 23 false false R24.htm 100250 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureStockBasedCompensationTables Stock-based Compensation (Tables) Tables http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureStockBasedCompensation 24 false false R25.htm 100260 - Disclosure - Recurring Fair Value Measurements (Tables) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/DisclosureRecurringFairValueMeasurementsTables Recurring Fair Value Measurements (Tables) Tables http://www.eloxxpharma.com/20230331/taxonomy/role/DisclosureRecurringFairValueMeasurements 25 false false R26.htm 100270 - Disclosure - Other Expense, Net (Tables) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureOtherExpenseNetTables Other Expense, Net (Tables) Tables http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureOtherExpenseNet 26 false false R27.htm 100280 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShare 27 false false R28.htm 100300 - Disclosure - Nature of the Business - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetail Nature of the Business - Additional Information (Detail) Details 28 false false R29.htm 100310 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Detail) Details 29 false false R30.htm 100320 - Disclosure - Property and Equipment - Property and Equipment, Net (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosurePropertyAndEquipmentPropertyAndEquipmentNetDetail Property and Equipment - Property and Equipment, Net (Detail) Details 30 false false R31.htm 100330 - Disclosure - Property and Equipment - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetail Property and Equipment - Additional Information (Detail) Details 31 false false R32.htm 100340 - Disclosure - Accrued Expenses - Accrued Expenses (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureAccruedExpensesAccruedExpensesDetail Accrued Expenses - Accrued Expenses (Detail) Details 32 false false R33.htm 100350 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail Debt - Additional Information (Detail) Details 33 false false R34.htm 100360 - Disclosure - Debt - Schedule of Future Principal Payments for Long-Term Debt (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureDebtScheduleOfFuturePrincipalPaymentsForLongTermDebtDetail Debt - Schedule of Future Principal Payments for Long-Term Debt (Detail) Details 34 false false R35.htm 100370 - Disclosure - Advances From Collaboration Partners, Legal and Other Contingencies - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureAdvancesFromCollaborationPartnersLegalAndOtherContingenciesAdditionalInformationDetail Advances From Collaboration Partners, Legal and Other Contingencies - Additional Information (Detail) Details 35 false false R36.htm 100390 - Disclosure - Stockholder's Equity - Additional Information (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetail Stockholder's Equity - Additional Information (Detail) Details 36 false false R37.htm 100400 - Disclosure - Stock-based Compensation - Transactions Related to Stock Options Awarded to Employees and Directors (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureStockBasedCompensationTransactionsRelatedToStockOptionsAwardedToEmployeesAndDirectorsDetail Stock-based Compensation - Transactions Related to Stock Options Awarded to Employees and Directors (Detail) Details 37 false false R38.htm 100420 - Disclosure - Stock-based Compensation - Summary of Allocated Stock-based Compensation Expense (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetail Stock-based Compensation - Summary of Allocated Stock-based Compensation Expense (Detail) Details 38 false false R39.htm 100430 - Disclosure - Recurring Fair Value Measurements - Schedule of Assets and liabilities measured at fair value on a recurring basis (Details) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/DisclosureRecurringFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails Recurring Fair Value Measurements - Schedule of Assets and liabilities measured at fair value on a recurring basis (Details) Details 39 false false R40.htm 100440 - Disclosure - Recurring Fair Value Measurements - Summary of Rollforward of Fair Value of Embedded Derivatives (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/DisclosureRecurringFairValueMeasurementsSummaryOfRollforwardOfFairValueOfEmbeddedDerivativesDetail Recurring Fair Value Measurements - Summary of Rollforward of Fair Value of Embedded Derivatives (Detail) Details 40 false false R41.htm 100450 - Disclosure - Other expense, Net - Schedule of Other Expense, Net (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/DisclosureOtherExpenseNetScheduleOfOtherExpenseNetDetail Other expense, Net - Schedule of Other Expense, Net (Detail) Details 41 false false R42.htm 100460 - Disclosure - Net Loss Per Share - Schedule of Net Loss and Weighted Average Number of Shares Used in Computing Basic and Diluted Net Loss Per Share (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfNetLossAndWeightedAverageNumberOfSharesUsedInComputingBasicAndDilutedNetLossPerShareDetail Net Loss Per Share - Schedule of Net Loss and Weighted Average Number of Shares Used in Computing Basic and Diluted Net Loss Per Share (Detail) Details 42 false false R43.htm 100470 - Disclosure - Net Loss Per Share - Potentially Dilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail) Sheet http://www.eloxxpharma.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedWeightedAverageSharesOutstandingDetail Net Loss Per Share - Potentially Dilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail) Details 43 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueToAffiliateCurrent in us-gaap/2022 used in 8 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. elox-20230331.htm 675, 679, 2204, 2205 [dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. elox-20230331.htm 1698, 1702, 1822, 1826 elox-20230331.htm elox-20230331.xsd elox-20230331_cal.xml elox-20230331_def.xml elox-20230331_lab.xml elox-20230331_pre.xml elox-ex10_1.htm elox-ex31_1.htm elox-ex31_2.htm elox-ex32_1.htm elox-ex32_2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true